Clinical pharmacology of Cilomilast

Clinical Pharmacokinetics
Geoff DownPeter Daley-Yates

Abstract

Chronic obstructive pulmonary disease (COPD) is a multicomponent, chronic inflammatory disease of the lungs with systemic complications. The majority of the inflammation occurs in the peripheral airways and lung parenchyma. It is a progressive disease, leading to disability and eventual death, despite conventional therapy. Inflammatory activity can be reduced by increasing intracellular cyclic adenosine-3',5'-monophosphate (cAMP) through inhibition of phosphodiesterase (PDE) IV, the principal PDE isoenzyme within pro-inflammatory cells, including eosinophils, mast cells, macrophages, lymphocytes, neutrophils and epithelial cells. PDE IV inhibition also has other effects, including relaxation of airway smooth muscle, suppression of smooth muscle mitogenesis and modulation of excitatory activity in pulmonary nerves. Cilomilast is a systemically available, second-generation, selective PDE IV inhibitor. It retains the therapeutic activity of the first-generation PDE IV inhibitors but lacks their profound emetic effect. Cilomilast is the first drug to demonstrate a reduction of tissue cells considered central to the ongoing inflammatory process (macrophages and CD8+ lymphocytes) in patients with stable COPD. Cilomilast is completely...Continue Reading

References

Oct 1, 1992·The Annals of Pharmacotherapy·A C Falcão, M Caramona
Jan 1, 1991·Pharmacology & Therapeutics·W J Thompson
Jan 1, 1990·Life Sciences·R E HowellW J Kinnier
Sep 1, 1989·The American Journal of Physiology·A Carl, K M Sanders
Oct 1, 1981·Clinical Pharmacology and Therapeutics·J J Grygiel, D J Birkett
Mar 1, 1994·American Journal of Respiratory and Critical Care Medicine·A Di StefanoM Saetta
May 15, 1994·Annals of Internal Medicine·P Raggi
May 15, 1994·Annals of Internal Medicine·E A Sanchez
Apr 1, 1993·Immunobiology·P ZabelM Schlaak
Dec 1, 1995·American Journal of Respiratory and Critical Care Medicine·P MaestrelliL M Fabbri
Jan 1, 1996·Progress in Medicinal Chemistry·M N Palfreyman, J E Souness
Mar 1, 1997·American Journal of Respiratory and Critical Care Medicine·T C O'ShaughnessyP K Jeffery
Feb 26, 1998·American Journal of Respiratory and Critical Care Medicine·T J Torphy
Oct 14, 1998·American Journal of Respiratory and Critical Care Medicine·A Di StefanoM Saetta
Jan 28, 1999·American Journal of Respiratory Cell and Molecular Biology·M FuhrmannN Suttorp
Nov 11, 1999·American Journal of Respiratory and Critical Care Medicine·S D Shapiro
Nov 11, 1999·American Journal of Respiratory and Critical Care Medicine·C BasbaumN McNamara
Nov 11, 1999·American Journal of Respiratory and Critical Care Medicine·R A Stockley
Jan 5, 2000·Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progrès Des Recherches Pharmaceutiques·M S Barnette
Mar 31, 2000·Current Opinion in Pulmonary Medicine·M S Barnette, D C Underwood
Jul 27, 2000·The New England Journal of Medicine·P J Barnes
Nov 23, 2000·The Annals of Otology, Rhinology, and Laryngology·T ShimizuY Sakakura
Feb 24, 2001·American Journal of Respiratory and Critical Care Medicine·G BolteJ Heinrich
Mar 29, 2001·Pulmonary Pharmacology & Therapeutics·J SpondM Minnicozzi
May 24, 2001·American Journal of Respiratory and Critical Care Medicine·M SaettaL M Fabbri
Jul 7, 2001·Clinical Therapeutics·B D ZussmanH Collie
Aug 3, 2001·Nature Reviews. Molecular Cell Biology·B Mayr, M Montminy
Nov 3, 2001·The Journal of Allergy and Clinical Immunology·D M Essayan
Jan 17, 2002·The Annals of Pharmacotherapy·J KellyH Fuder
May 30, 2002·American Journal of Respiratory Cell and Molecular Biology·Tadashi KohyamaStephen I Rennard
Sep 5, 2002·Nature Reviews. Molecular Cell Biology·Kristen L PierceRobert J Lefkowitz

❮ Previous
Next ❯

Citations

Jul 16, 2009·Drug Metabolism Reviews·Alan BoobisKeith Tipton
Aug 23, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Donald S NuzumSamir A Kouzi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.